Related Experiment Videos

Retsat promotes synovial mesenchymal stem cell senescence and aggravates osteoarthritis by inhibiting the PPARγ/RXR

Yanbin Shi1, Song Wu1, Chi Liang1

  • 1Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha City, Hunan Province 410013, China.

Osteoarthritis and Cartilage
|July 1, 2026
PubMed
Abstract

Insights

Silencing retinol saturase (Retsat) in senescent mesenchymal stem cells improved osteoarthritis by promoting proliferation and reducing inflammation. This targeted approach enhanced cartilage repair via the PPARγ/RXR pathway in a murine OA model.

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Cell Biology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease with limited treatment options.
  • Stem cell therapy shows promise for OA, but understanding cellular mechanisms is crucial.
  • Senescent synovial mesenchymal stem cells (SMSCs) contribute to OA pathogenesis.

Purpose of the Study:

  • Investigate metabolic alterations in senescent SMSCs.
  • Determine the role of retinol saturase (Retsat) in SMSC regulation and OA.
  • Elucidate the molecular mechanisms of Retsat in OA.

Main Methods:

  • Comparative metabolomic profiling of young vs. aged SMSCs.
  • siRNA-mediated silencing of Retsat in SMSCs.
  • In vitro functional assays (proliferation, senescence, inflammation).
  • In vivo evaluation using a murine OA model.

Main Results:

  • Trans-13,14-dihydroxyretinol identified as a key metabolite linked to altered retinol metabolism.
  • Retsat silencing enhanced SMSC proliferation, reduced senescence and inflammation.
  • Retsat inhibition activated the PPARγ/RXR pathway, improving SMSC viability.
  • In vivo, Retsat-silenced SMSCs ameliorated OA, reducing cartilage damage and senescence markers.

Conclusions:

  • Targeting Retsat offers a potential therapeutic strategy for OA.
  • Silencing Retsat promotes cartilage repair by enhancing senescent SMSC activity.
  • The PPARγ/RXR pathway is a key mediator in Retsat's effect on OA.
Keywords:
MetabolomicsOsteoarthritisRetsatSenescenceSynovial mesenchymal stem cells

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...